The human olfactory system: An anatomical and cytoarchitectonic study of the anterior olfactory nucleus

Neuroanatomy Research Advances

Volumn , Issue , 2010, Pages 171-182

  Sánchez, Daniel Saiz ^a   Bañón, Isabel Úbeda ^a   de la Rosa Prieto, Carlos ^a   Palacios, Lucía Argandoña ^b   Muñozguren, Susana García ^b   Insausti, Ricardo ^a   Marcos, Alino Martínez ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862857795     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (55)

1. Argandoña-Palacios L., Saiz-Sánchez D., Úbeda-Bañón I., De la Rosa-Prieto C., García-Muñozguren S., Villanueva P., Insausti R., Martinez-Marcos A. (2008). Somatostatin-and TAU protein immunoreactivities in the anterior olfactory nucleus in Alzheimer disease Society for Neuroscience. Washington. 739.735/O731
2. Braak H., Del Tredici K., Rub U., de Vos R. A., Jansen Steur E. N., Braak E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of aging24(2):197-211.
3. Burns A. (2000). Might olfactory dysfunction be a marker of early Alzheimer's disease? Lancet355(9198):84-85.
4. Clerico D. M., W.C. T., Lanza D. C. 2003. Anatomy of the human nasal passages. In: Doty RL, editor. Handbook of Olfaction and Gustation. New York: Marcel Dekker. pp. 1-16.
5. Crosby C. E., Humphrey T. (1941). Studies of the vertebrate telencephalon. II. The nuclear pattern of the anterior olfactory nucleus, tuberculum olfactorium and the amygdaloid complex in adult man. The Journal or Comparative Neurology74(2):309-353.
6. Curtis M. A., Kam M., Nannmark U., Anderson M. F., Axell M. Z., Wikkelso C., Holtas S., van Roon-Mom W. M., Bjork-Eriksson T., Nordborg C., Frisen J., Dragunow M., Faull R. L., Eriksson P. S. (2007). Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science(New York, NY 315(5816):1243-1249.
7. Daniel S. E., Hawkes C. H. (1992). Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet340(8812):186.
8. Del Tredici K., Rub U., De Vos R. A., Bohl J. R., Braak H. (2002). Where does parkinson disease pathology begin in the brain? Journal of neuropathology and experimental neurology61(5):413-426.
9. Ding X., Dahl A. R. 2003. Olfactory Mucosa: Composition, Enzymatic localization, and Metabolism. In: Doty RL, editor. Handbook of Olfaction and Gustation. New York: Marcel Dekker. pp. 51-73.
10. Doty R. L. 2003. Odor Perception in Neurodegenerative Diseases. In: Doty RL, editor. Handbook of Olfaction and Gustation. New York: Marcel Dekker. pp. 479-501.
11. Esiri M. M., Wilcock G. K. (1984). The olfactory bulbs in Alzheimer's disease. Journal of neurology, neurosurgery, and psychiatry47(1):56-60.
12. Hawkes C. (2006). Olfaction in neurodegenerative disorder. Advances in oto-rhinolaryngology63:133-151.
13. Hawkes C. H., Shephard B. C., Daniel S. E. (1999). Is Parkinson's disease a primary olfactory disorder? Qjm92(8):473-480.
14. Hoogland P. V., Huisman E. (1999). Tyrosine hydroxylase immunoreactive structures in the aged human olfactory bulb and olfactory peduncle. Journal of chemical neuroanatomy17(3):153-161.
15. Hoogland P. V., van den Berg R., Huisman E. (2003). Misrouted olfactory fibres and ectopic olfactory glomeruli in normal humans and in Parkinson and Alzheimer patients. Neuropathology and applied neurobiology29(3):303-311.
16. Humphrey T., Crosby C. E. (1938). The human olfactory bulb. Hosp Bull Univ Mich4:61-62.
17. Ikemoto K., Nagatsu I., Kitahama K., Jouvet A., Nishimura A., Nishi K., Maeda T., Arai R. (1998). A dopamine-synthesizing cell group demonstrated in the human basal forebrain by dual labeling immunohistochemical technique of tyrosine hydroxylase and aromatic L-amino acid decarboxylase. Neuroscience letters243(1-3):129-132.
18. Insausti R., Marcos P., Arroyo-Jimenez M. M., Blaizot X., Martinez-Marcos A. (2002). Comparative aspects of the olfactory portion of the entorhinal cortex and its projection to the hippocampus in rodents, nonhuman primates, and the human brain. Brain research bulletin57(3-4):557-560.
19. Korten J. J., Meulstee J. (1980). Olfactory disturbances in Parkinsonism. Clinical neurology and neurosurgery82(2):113-118.
20. Kovacs I., Torok I., Zombori J., Kasa P. (1996). Neuropathologic changes in the olfactory bulb in Alzheimer's disease. Neurobiology(Budapest, Hungary) 4(1-2):123-126.
21. Kovacs T. (2004). Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing research reviews3(2):215-232.
22. Kovacs T., Cairns N. J., Lantos P. L. (1999). beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. Neuropathology and applied neurobiology25(6):481-491.
23. Kovacs T., Cairns N. J., Lantos P. L. (2001). Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport12(2):285-288.
24. Kranick S. M., Duda J. E. (2008). Olfactory dysfunction in Parkinson's disease. Neuro-Signals16(1):35-40.
25. Lerner A., Bagic A. (2008). Olfactory pathogenesis of idiopathic Parkinson disease revisited. Mov Disord23(8):1076-1084.
26. Liss L. (1956). The histology of the human olfactory bulb and the extracerebral part of the tract; a study with silver-carbonate. The Annals of otology, rhinology, and laryngology65(3):680-691.
27. Mai J. K., Paxinos G., Voss T. (2008). Atlas of the Human Brain. New York: Elsevier.
28. Menco B. P. M., Morrison E. D. 2003. Morphology of the mammalian olfactory epithelium: form, fine structure, function, and pathology. In: Doty RL, editor. Handbook of Olfaction and Gustation. New York: Marcel Dekker. pp. 17-49.
29. Meyer G., Gonzalez-Hernandez T., Carrillo-Padilla F., Ferres-Torres R. (1989). Aggregations of granule cells in the basal forebrain (islands of Calleja): Golgi and cytoarchitectonic study in different mammals, including man. The Journal of comparative neurology284(3):405-428.
30. Mohedano-Moriano A., Martinez-Marcos A., Munoz M., Arroyo-Jimenez M. M., Marcos P., Artacho-Perula E., Blaizot X., Insausti R. (2005). Reciprocal connections between olfactory structures and the cortex of the rostral superior temporal sulcus in the Macaca fascicularis monkey. The European journal of neuroscience22(10):2503-2518.
31. Muller A., Mungersdorf M., Reichmann H., Strehle G., Hummel T. (2002). Olfactory function in Parkinsonian syndromes. J Clin Neurosci9(5):521-524.
32. Nakashima T., Kimmelman C. P., Snow J. B., Jr. (1985). Olfactory marker protein in the human olfactory pathway. Arch Otolaryngol111(5):294-297.
33. Ohm T. G., Braak E., Probst A. (1988a). Somatostatin-14-like immunoreactive neurons and fibres in the human olfactory bulb. Anatomy and embryology179(2):165-171.
34. Ohm T. G., Braak E., Probst A., Weindl A. (1988b). Neuropeptide Y-like immunoreactive neurons in the human olfactory bulb. Brain research451(1-2):295-300.
35. Ohm T. G., Braak H. (1987). Olfactory bulb changes in Alzheimer's disease. Acta neuropathologica73(4):365-369.
36. Pearce R. K., Hawkes C. H., Daniel S. E. (1995). The anterior olfactory nucleus in Parkinson's disease. Mov Disord10(3):283-287.
37. Peters J. M., Hummel T., Kratzsch T., Lotsch J., Skarke C., Frolich L. (2003). Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques. The American journal of psychiatry160(11):1995-2002.
38. Ponsen M. M., Stoffers D., Booij J., van Eck-Smit B. L., Wolters E., Berendse H. W. (2004). Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Annals of neurology56(2):173-181.
39. Price J. L. 1990. Olactory System. In: Paxinos G, editor. The Human Nervous System. San Diego: Academic Press. pp. 979-998.
40. Ross G. W., Petrovitch H., Abbott R. D., Tanner C. M., Popper J., Masaki K., Launer L., White L. R. (2008). Association of olfactory dysfunction with risk for future Parkinson's disease. Annals of neurology63(2):167-173.
41. Saiz-Sánchez D., Úbeda-Bañón I., De la Rosa-Prieto C., García-Muñozguren S., Argandoña-Palacios L., Insausti R., Martinez-Marcos A. (2008). Distribution of calbindin and TAU protein immunoreactivity in the anterior olfactory nucleus in Alzheimer disease Society for Neurscience. Washington. 739.734/N712.
42. Sanai N., Berger M. S., Garcia-Verdugo J. M., Alvarez-Buylla A. (2007). Comment on " Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension". Science(New York, NY 318(5849):393; author reply 393.
43. Scherfler C., Schocke M. F., Seppi K., Esterhammer R., Brenneis C., Jaschke W., Wenning G. K., Poewe W. (2006). Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. Brain129(Pt 2):538-542.
44. Serby M. (1987). Olfactory deficits in Alzheimer's disease. Journal of neural transmission24:69-77.
45. Smith R. L., Baker H., Greer C. A. (1993). Immunohistochemical analyses of the human olfactory bulb. The Journal of comparative neurology 333(4):519-530.
46. Smith R. L., Baker H., Kolstad K., Spencer D. D., Greer C. A. (1991). Localization of tyrosine hydroxylase and olfactory marker protein immunoreactivities in the human and macaque olfactory bulb. Brain research548(1-2):140-148.
47. Smutzer G. S., Doty R. L., Arnold S. E., Trojanowski J. Q. 2003. Olfactory system neuropathology in Alzheimer's Disease, Parkinson's Disease, and Schizophrenia. In: Doty RL, editor. Handbook of Olfaction and Taste. New York: Marcel Dekker. pp. 503-523.
48. Stiasny-Kolster K., Doerr Y., Moller J. C., Hoffken H., Behr T. M., Oertel W. H., Mayer G. (2005). Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain128(Pt 1):126-137.
49. Struble R. G., Clark H. B. (1992). Olfactory bulb lesions in Alzheimer's disease. Neurobiology of aging13(4):469-473.
50. ter Laak H. J., Renkawek K., van Workum F. P. (1994). The olfactory bulb in Alzheimer disease: a morphologic study of neuron loss, tangles, and senile plaques in relation to olfaction. Alzheimer disease and associated disorders8(1):38-48.
51. Tolosa E., Compta Y., Gaig C. (2007). The premotor phase of Parkinson's disease. Parkinsonism & related disorders 13 Suppl:S2-7.
52. Tsuboi Y., Wszolek Z. K., Graff-Radford N. R., Cookson N., Dickson D. W. (2003). Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Neuropathology and applied neurobiology29(5):503-510.
53. Úbeda-Bañón I., Saiz-Sánchez D., de la Rosa-Prieto C., Argandoña-Palacios L., García-Muñozguren S., Martinez-Marcos A. (2009). Lewy bodies affect non-dopaminegic cells in the human olfactory system in Parkinson's disease. under review.
54. Úbeda-Bañón I., Saiz-Sánchez D., De la Rosa-Prieto C., García-Muñozguren S., Argandoña-Palacios L., Martinez-Marcos A. (2008a). Anosmia as early predictor of parkinson disease: aTyrosine hydroxylase immunoreactivity in the human olfactory bulb and anterior olfactory nucleus. International Symposium on Olfaction and Taste. San Francisco. P52.
55. Úbeda-Bañón I., Saiz-Sánchez D., De la Rosa-Prieto C., García-Muñozguren S., Argandoña-Palacios L., Martinez-Marcos A. (2008b). Anosmia as early predictor of parkinson disease: Calbindin immunoreactivity in the human olfactory bulb and anterior olfactory nucleus. Novel Advances in Parkinson's Disease (Fundación Ramón Areces). Salamanca. P-20.